Medistep Healthcare IPO is a small and medium enterprise (SME) public offer worth ₹16.10 crore. It will be open for investors to apply from August 8 to August 12, 2025. Out of this, ₹16.10 crore is from new shares, and ₹0 crore is from existing shareholders selling their shares.
Each share has a face value of ₹10, and the price range is Fixed Price of ₹43 per share. Retail investors must apply for at least 2 lots, with 1 lot containing 3,000 shares—so a minimum of 6,000 shares, costing around ₹2,58,000(Upper Price Band). The IPO is expected to list on the NSE SME platform on August 18, 2025.
Stay tuned for more updates on the Medistep Healthcare SME IPO, including details about the company, its financials, live subscription status, allotment, listing date, and listing price.
📈 IPO Listing Details
| IPO Listing Date | 18th August 2025 |
| ISIN | |
| NSE Symbol | |
| BSE Script Code | |
| Issue Price | ₹43 |
| Listing Price | [₹0] |
| Listing Gain/Loss (%) | [+0%] |
📈 Listing Day Trading Information
| Price | NSE |
|---|---|
| Share Allotment Price(Issue Price) | 0 |
| Open | 0 |
| High | 0 |
| Low | 0 |
| VWAP | 0 |
| Close | 0 |
📊 IPO Details
| IPO Type | SME |
|---|---|
| IPO Method | Fixed Price |
| IPO Open Date | 8th August 2025 |
| IPO Close Date | 12th August 2025 |
| IPO Listing Date | 18th August 2025 |
| Price Band | ₹43 per share |
| Lot Size | 3000 Shares (Minimum Bids 2000 Shares) |
| Face Value | 10 |
| Issue Size | ₹16.10 Crores (approx.)* |
| Fresh Issue | ₹16.10 Crores (approx.)* |
| Offer for Sale (OFS) | ₹0 Crores (approx.)* |
| Listing Exchange | NSE (NSE is the designated stock exchange) |
🔔 IPO Timeline
⏳ Medistep Healthcare IPO Subscription Status (Day-wise)
| Day | QIB | NII | RII | Employees | Total |
|---|---|---|---|---|---|
| Day 1 | x | x | x | x | x |
| Day 2 | x | x | x | x | x |
| Day 3 | x | x | x | x | x |
📋 Medistep Healthcare IPO reservation table
| Investor Category | Shares Offered | Shares Bid For | Times Subscribed |
|---|---|---|---|
| Anchor Investors | 0 | 0 | 1x |
| Market Maker Portion | 1,89,000/- | 0 | 1x |
| Other than Individual Investors | 17,76,000/- | 0 | x |
| Individual Investors | 17,79,000/- | 0 | x |
| Employee Reserved category | 0 | 0 | x |
| Total | 37,44,000/- | x |
📦 Medistep Healthcare IPO Lot Size
Table is Prepared at the upper end of the price band (₹43).
| Application | Lot Size | No. of Shares | Amount |
|---|---|---|---|
| Individual (Min) | |||
| Individual (Max) | |||
| S-HNI (Min) | |||
| S-HNI (Max) | |||
| B-HNI (Min) |
👤👥 Promoter Shareholding Table (Pre & Post Issue)
Its promoters are Mr. Girdhari Lal Prajapat, Mr. Dabhi Vipul Gobarbhai, and Ms. Prajapati Hetalben Girdharilal.
| Shareholder | Pre-Issue Holding (%) | Post-Issue Holding (%) |
|---|---|---|
| Promoters | 93.62% | 68.95% |
| Others (Public / Investors) | 6.38% | 31.05% |
| Total | 100% | 100% |
🏢 Company Overview
Medistep Healthcare Limited was incorporated on June 5, 2023, as a public limited company under the Companies Act, 2013, in Ahmedabad. The company operates in the pharmaceutical industry, engaging in the trading of pharmaceutical products, intimate care and hygiene items, surgical products, and nutraceuticals. It also manufactures intimate care and nutraceutical products.
As part of its expansion, Medistep Healthcare Limited acquired the business of M/s MG Pharma, a proprietorship owned by one of its promoters, Ms. Prajapati Hetalben Girdharilal. This acquisition was completed through a business transfer agreement on July 2, 2023, integrating all operations, assets, and liabilities into the company.MG Pharma, established in July 2018, was active in the trading and distribution of pharmaceutical and healthcare products. The acquisition allowed Medistep Healthcare Limited to strengthen its presence in the market.
In January 2024, the company began manufacturing its own intimate care products, such as sanitary pads, and nutraceutical items like energy powders.
🎯 Objects of the Offer
- Capital expenditure for purchasing new plant and machineries.
- Working Capital Requirement.
- General corporate purposes.
- Issue Expenses.
₹ Financial Snapshot (As of and For the Fiscal Ended on)
| Particulars | 31-Mar-2025 | For the period from 3rd July, 2023 to 31st March, 2024 | For the period from 1st April, 2023 to 2nd July, 2023 | 31-Mar-2023 |
|---|---|---|---|---|
| Revenue (₹ Cr) | 49.65 | 31.62 | 7.46 | 27.65 |
| Revenue (₹ Cr)(Including Other Income) | 49.66 | 31.63 | 7.46 | 27.74 |
| Profit After Tax (₹ Cr) | 4.14 | 2.91 | .41 | .92 |
| Profit After Tax Margin (%)(On Total Revenue) | 8.35% | 9.22% | 5.55% | 3.33% |
| Earnings per share (in ₹) | 4.01 | 19.96 | - | - |
| Total Assets (₹ Cr) | 22.99 | 14.96 | 11.50 | 14.66 |
| Net Worth (₹ Cr) | 16.83 | 11.69 | 1.42 | 1.07 |
📈 Key Performance Indicators
| Particulars | FY2024-25 | For the period from 3rd July, 2023 to 31st March, 2024 | For the period from 1st April, 2023 to 2nd July, 2023 | FY2022-23 |
|---|---|---|---|---|
| EBITDA (₹ Cr) | 5.60 | 3.96 | .59 | 1.34 |
| EBITDA Margin (%) | 11.27% | 12.51% | 7.86% | 4.84% |
| Return on Net Worth (%) | 29.06% | 44.44% | 33.20% | 131.24% |
| Return on Capital Employed (RoCE %) | 38.91% | 59.10% | 40.00% | 109.62% |
| Debt Equity Ratio | .04 | .03 | .28 | .50 |
| Operating Cash Flows(₹ Cr) | .02 | (7.11) | .15 | .44 |
⚔️ Comparison with Listed Competitors
| Company Name | CMP (July 30,2025) | Revenue from Operations (FY24-25, ₹ in Cr) | Face Value (₹) | EPS (₹) | P/E Ratio (x) | RoNW (%) | NAV (₹) | EBITDA Margin (%) FY 25 | PAT Margin (%) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|---|
| Medistep Healthcare Limited | 43 | 49.65 | 10 | 4.01 | 10.72 | 24.62% | 16.28 | 11.27% | 8.35% | 3.73 |
| Fabino Enterprises Limited | 26 | 18.04 | 10 | .63 | 41.27 | 3.12% | 20.42 | .92% | .73% | 9.32 |
| Achyut Healthcare Limited | 4.18 | 3.05 | 1 | .02 | 209 | 1.77% | 1.33 | -6.63% | 17.97% | 1.75 |
Data is based on the latest available financials 2024-2025. and may differ from actual market movements.
🔍 Strengths & Risks
💪 Key Strengths
- Strong distribution networks,
- Low-cost products,
- Direct contact with Retail as well as distributors,
- Experienced Promoters and Senior Management with extensive domain knowledge,
- Quality assurance and control,
- Market Potential,
- Investment in latest technology and maintain our edge in the market.
⚠️ Key Risks
- Intense competition from established brands
- Fluctuating raw material prices
- Changes in consumer preference
📞 Key Contacts for Medistep Healthcare IPO
| Company Contact Medistep Healthcare Limited Ms. Sashi Kala Bhutra(Company Secretary and Compliance Officer) 05, S. No-245/B, Plot-19, T.P.S. 56, Free Way Trade Center, Nr.A-One Hotel, N.H.-8, Narol Gam, Narol, Ahmadabad City, Daskroi, Gujarat, India, 382405 📧 Email: cs@medistephc.com 🌐 Website: www.medistephc.com | Registrar to the Issue CAMEO CORPORATE SERVICES LIMITED “Subramaniam Building”, No. 1, Club House Road, Chennai-600002 🌐 Website: www.cameoindia.com 📞 Phone: +91-44-40020700/28460390 📧 Email: ipo@cameoindia.com |
📘 Book Running Lead Managers (BRLMs)
| BRLM Full Name |
|---|
| FAST TRACK FINSEC PRIVATE LIMITED. |
For full contact details including representatives, emails, and phone numbers, of BRLM's please refer to the Red Herring Prospectus (RHP).
📂Important IPO Documents
- 📄 Red Herring Prospectus (RHP)
- 📄 Draft Red Herring Prospectus (DRHP)
- 📄 Anchor Investors Allocation Report.
- 📄 Basis of Allotment(Published After allotment)
📖FAQ's
- ChatGPT Parental Control: New Feature to Keep Kids Safe 2025
- फैबटेक टेक्नोलॉजीज 2025 (Fabtech Technologies IPO) सम्पुर्ण जानकारी हिन्दी में
- Classic Electrodes IPO Date, Price , Allotment ,Subscription Details 2025
- BSE SME IPO LIST
- अमांता हेल्थकेयर आईपीओ की सम्पुर्ण जानकारी हिन्दी में (Amanta Healthcare IPO)
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments and consult their investment advisor before making any investment decisions. While we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose.
Disclaimer: Upcomingipo is not responsible for any errors or omissions or for the results obtained from the use of such information. Any reliance you place on such information is therefore strictly at your own risk. User shall confirm the accuracy of the information before using of the same from the official website of respective authority in the respective subject at user end.